Skip to main content

Zinplava Prices, Coupons and Patient Assistance Programs

Zinplava (bezlotoxumab) is a member of the immune globulins drug class and is commonly used for Prevention of Recurrent Clostridioides difficile Infection.

The cost for Zinplava intravenous solution (25 mg/mL) is around $4,011 for a supply of 40 milliliters, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the discount card which is accepted at most U.S. pharmacies.

Zinplava prices

Intravenous Solution

Quantity Per unit Price
40 milliliters $100.27 $4,010.90

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Zinplava Coupons, Copay Cards and Rebates

Zinplava offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional. Printable Discount Card

The free Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Print Free Discount Card

Note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Zinplava Merck Co-Pay Assistance Program

Eligible commercially insured patients will pay $100 per infusion with a maximum benefit of $3,700 for one vial per calendar year; if 2 vials are required for one infusion then the maximum benefit is $7,500 per calendar year; for additional information contact the program at 877-709-4455.

Applies to:
Number of uses:
per prescription per calendar year
December 31, 2023

Form more information phone: 877-709-4455 or Visit website

Patient Assistance & Copay Programs for Zinplava

Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.

Provider: Merck Connect

Eligibility requirements:
  1. Determined case by case
  2. Not disclosed
  3. Medically Necessary as determined by a Doctor
  4. Must be treated by US licensed healthcare provider
  5. Resources for HEALTHCARE PROFESSIONALS ONLY. The Physician must register to access tools and materials for patient support, product sample requests, up-to-date professional resources, and other Merck professional sites.
Applicable drugs:
  • Zinplava (bezlotoxumab) Injection; IV

More information please phone: 800-489-5119 Visit Website

Provider: Merck Access Program for Zinplava

Eligibility requirements:
  1. Determined case by case
  2. Not disclosed
  3. Medically appropriate condition/diagnosis
  4. Must be residing in the US or a US territory, and under the care of a US physician
  5. Patient must sign the enrollment form to give the program permission to access their financial information in order to determine eligibility. Patients in need who appear not to qualify should still call. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.
Applicable drugs:
  • Zinplava (bezlotoxumab) Injection; IV

More information please phone: 877-709-4455 Visit Website